Animal and human studies indicate TGFβ-system dysregulations and impaired neurogenesis as a common feature of neurodegenerative disorders, particularly in ALS, Alzheimer’s disease, and Huntington’s disease [14, 43–47]. Here, TGFB1 is linked to Alzheimer disease.